(Medical Xpress)—Need another reason to dust off those running shoes in the back of the closet? It turns out that running longer distances actually decreases a person's risk of osteoarthritis and hip replacements, according ...
Mar 1, 2013
0
0
Women appear to have a higher risk of implant failure than men following total hip replacement after considering patient-, surgery-, surgeon-, volume- and implant-specific risk factors, according to a report published Online ...
Feb 19, 2013
0
0
Researchers who sought to determine whether pricing information for a total hip replacement could be obtained from hospitals and physicians found getting such information was often difficult and that there were wide variations ...
Feb 11, 2013
0
0
A Case Western Reserve University chemistry professor has begun imbedding magnetic nanoparticles in the toughest of plastics to understand why more than 40,000 Americans must replace their knee and hip replacements annually.
Feb 4, 2013
0
0
Technological advancements in medicine have allowed patients suffering from musculoskeletal conditions such as hip and knee pain to regain mobility and live relatively pain-free. But some "high risk" surgical devices that ...
Jan 22, 2013
0
0
(HealthDay)—Younger, taller, and heavier patients who undergo primary total hip replacement (THR) are at a greater risk of needing a revision surgery, according to research published in the December issue of Arthritis Care ...
Dec 17, 2012
0
0
Patients who make $35,000 a year or less report better outcomes after knee replacement surgery than people who earn more, research by Mayo Clinic and the University of Alabama at Birmingham shows. The lower-income patients ...
Nov 10, 2012
0
0
(Medical Xpress)—Move over Nike Plus. University of Utah (the U) professor Stacy Bamberg, of the Department of Mechanical Engineering, is developing a shoe insole that can gather comparable data to Nike's popular line of ...
Nov 9, 2012
0
0
Risk of ischemic stroke increases by nearly 4.7-fold and hemorrhagic stroke 4.4-fold during the first two weeks after total hip replacement surgery, according to new research in the American Heart Association journal Stroke.
Nov 8, 2012
0
0
(HealthDay)—Approval of the anti-clotting drug Xarelto (rivaroxaban) has been expanded by the U.S. Food and Drug Administration to include treating deep vein thrombosis (DVT) or pulmonary embolism.
Nov 5, 2012
0
0
